Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow
Xavier Fradera1, Joey L Methot2, Abdelghani Achab2
1Computational and Structural Chemistry, Merck & Co., Inc., Boston, MA, USA.
Abstract:
PI3Kδ mediates key immune cell signaling pathways and is a target of interest for multiple indications in immunology and oncology. Here we report a structure-based scaffold-hopping strategy for the design of chemically diverse PI3Kδ inhibitors. Using this strategy, we identified several scaffolds that can be combined to generate new PI3Kδ inhibitors with high potency and isoform selectivity. In particular, an oxindole-based scaffold was found to impart exquisite selectivity when combined with several hinge binding motifs.
More Related Videos
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Group Design
Factorial Design
What is Natural Selection?
Antibiotic Selection
Design Example: Designing a Residential Plumbing System


